tirzepatide as compared with semaglutide for the treatment of obesity Tirzepatide vs Semaglutide: What's the

See why an Ozempic plateau may reflect digestion, stress, and gut microbiome changes, not just calories

It is labeled for use as an adjunct to diet and exercise for chronic weight management in adults classified as obese (body mass index [BMI] of 30 kg per m2 or greater) or overweight (BMI of 27 kg per m2 or greater) in the presence of one weight-related comorbidity

Find out if you qualify for gastric bypass surgery, including BMI criteria, related health conditions, psychological readiness, and the pre-surgery assessment process.

Dermatologist-developed, the best hair growth products for thinning hair

What this means for the Indian market: Increased accessibility of Semaglutide therapy Greater competition leading to potential price rationalization Expansion of obesity management as a mainstream therapeutic segment A new strategic battleground for pharma marketing teams For healthcare professionals and the pharma industry, this could be one of the most competitive launches in the metabolic segment in the coming years

Stopping semaglutide typically triggers rapid appetite recovery and weight regain within weeks to months, with rebound effects varying by individual metabolic factors, treatment duration, and lifestyle adherence